Across TCGA pan-cancer cohorts, FAM155A-IT1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of FAM155A-IT1’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where FAM155A-IT1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FAM155A-IT1 is over-expressed in tumor, although a few such as ESCA show the opposite, repressed pattern.

STAD, CHOL, and BRCA are the cancer types where FAM155A-IT1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FAM155A-IT1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	+0.212	.026	4	view →
CHOL	All	All	+0.114	.027	2	view →
BRCA	All	III,IV	+0.071	.001	2	view →
LIHC	All	All	+0.017	.038	2	view →
ESCA	Female	All	−0.276	.027	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: FAM155A-IT1 RNA expression & survival · all FAM155A-IT1 data types